Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary 40 years of experience

V. Fülöp, Iván Szigetvári, János Szepesi, György Végh, János Demeter, Ross S. Berkowitz

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To review treatment results of high-risk metastatic gestational trophoblastic neoplasia (GTN) over the last 40 years in Hungary. STUDY DESIGN: Between January 1, 1977, and December 31, 2016, 197 patients were treated with high-risk metastatic GTN. Primary chemotherapy was selected based upon the patient’s stage of GTN and prognostic score. Surgery was performed mainly to either resect sites of chemotherapy-resistant disease or to treat acute complications. RESULTS: As a primary therapy, MAC was used in 124 high-risk cases and EMA-CO in 42 high-risk cases; out of those cases, 114 (91.9%) and 33 (78.6%) patients, respectively, achieved complete remission. As compared to the administration of the MAC regimen, during the last 10 years the use of EMA-CO primary combination chemotherapy had favorable outcomes and was significantly increased among our metastatic highrisk patients with more serious GTN (MAC/EMA-CO ratios between 1977–2006: 5.9 [100/17] and between 2007–2016: 0.9 [24/25]; p<0.05). Over the period of 1977–2016 54/197 (27.4%) hysterectomies were performed, while metastases were resected in 37/197 (18.8%) of high-risk patients. CONCLUSION: Patients with high-risk metastatic GTN should primarily be treated with EMA-CO com bination chemotherapy, while surgery still plays a valuable role in the disease management.

Original languageEnglish
Pages (from-to)240-248
Number of pages9
JournalJournal of Reproductive Medicine
Volume63
Issue number3
Publication statusPublished - Jan 1 2018

Fingerprint

Gestational Trophoblastic Disease
Hungary
Carbon Monoxide
Drug Therapy
Therapeutics
Disease Management
Combination Drug Therapy
Hysterectomy
Neoplasm Metastasis

Keywords

  • Anatomical stages
  • Chemotherapy
  • Choriocarcinoma
  • Gestational trophoblastic disease
  • Gestational trophoblastic neoplasia
  • High-risk metastatic gestational trophoblastic neoplasia
  • Hysterectomy
  • Metastasis surgery
  • Prognostic score

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary 40 years of experience. / Fülöp, V.; Szigetvári, Iván; Szepesi, János; Végh, György; Demeter, János; Berkowitz, Ross S.

In: Journal of Reproductive Medicine, Vol. 63, No. 3, 01.01.2018, p. 240-248.

Research output: Contribution to journalArticle

Fülöp, V, Szigetvári, I, Szepesi, J, Végh, G, Demeter, J & Berkowitz, RS 2018, 'Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary 40 years of experience', Journal of Reproductive Medicine, vol. 63, no. 3, pp. 240-248.
Fülöp, V. ; Szigetvári, Iván ; Szepesi, János ; Végh, György ; Demeter, János ; Berkowitz, Ross S. / Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary 40 years of experience. In: Journal of Reproductive Medicine. 2018 ; Vol. 63, No. 3. pp. 240-248.
@article{1dbbaa4a80144303b8851638d4e69d27,
title = "Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary 40 years of experience",
abstract = "OBJECTIVE: To review treatment results of high-risk metastatic gestational trophoblastic neoplasia (GTN) over the last 40 years in Hungary. STUDY DESIGN: Between January 1, 1977, and December 31, 2016, 197 patients were treated with high-risk metastatic GTN. Primary chemotherapy was selected based upon the patient’s stage of GTN and prognostic score. Surgery was performed mainly to either resect sites of chemotherapy-resistant disease or to treat acute complications. RESULTS: As a primary therapy, MAC was used in 124 high-risk cases and EMA-CO in 42 high-risk cases; out of those cases, 114 (91.9{\%}) and 33 (78.6{\%}) patients, respectively, achieved complete remission. As compared to the administration of the MAC regimen, during the last 10 years the use of EMA-CO primary combination chemotherapy had favorable outcomes and was significantly increased among our metastatic highrisk patients with more serious GTN (MAC/EMA-CO ratios between 1977–2006: 5.9 [100/17] and between 2007–2016: 0.9 [24/25]; p<0.05). Over the period of 1977–2016 54/197 (27.4{\%}) hysterectomies were performed, while metastases were resected in 37/197 (18.8{\%}) of high-risk patients. CONCLUSION: Patients with high-risk metastatic GTN should primarily be treated with EMA-CO com bination chemotherapy, while surgery still plays a valuable role in the disease management.",
keywords = "Anatomical stages, Chemotherapy, Choriocarcinoma, Gestational trophoblastic disease, Gestational trophoblastic neoplasia, High-risk metastatic gestational trophoblastic neoplasia, Hysterectomy, Metastasis surgery, Prognostic score",
author = "V. F{\"u}l{\"o}p and Iv{\'a}n Szigetv{\'a}ri and J{\'a}nos Szepesi and Gy{\"o}rgy V{\'e}gh and J{\'a}nos Demeter and Berkowitz, {Ross S.}",
year = "2018",
month = "1",
day = "1",
language = "English",
volume = "63",
pages = "240--248",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "3",

}

TY - JOUR

T1 - Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary 40 years of experience

AU - Fülöp, V.

AU - Szigetvári, Iván

AU - Szepesi, János

AU - Végh, György

AU - Demeter, János

AU - Berkowitz, Ross S.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - OBJECTIVE: To review treatment results of high-risk metastatic gestational trophoblastic neoplasia (GTN) over the last 40 years in Hungary. STUDY DESIGN: Between January 1, 1977, and December 31, 2016, 197 patients were treated with high-risk metastatic GTN. Primary chemotherapy was selected based upon the patient’s stage of GTN and prognostic score. Surgery was performed mainly to either resect sites of chemotherapy-resistant disease or to treat acute complications. RESULTS: As a primary therapy, MAC was used in 124 high-risk cases and EMA-CO in 42 high-risk cases; out of those cases, 114 (91.9%) and 33 (78.6%) patients, respectively, achieved complete remission. As compared to the administration of the MAC regimen, during the last 10 years the use of EMA-CO primary combination chemotherapy had favorable outcomes and was significantly increased among our metastatic highrisk patients with more serious GTN (MAC/EMA-CO ratios between 1977–2006: 5.9 [100/17] and between 2007–2016: 0.9 [24/25]; p<0.05). Over the period of 1977–2016 54/197 (27.4%) hysterectomies were performed, while metastases were resected in 37/197 (18.8%) of high-risk patients. CONCLUSION: Patients with high-risk metastatic GTN should primarily be treated with EMA-CO com bination chemotherapy, while surgery still plays a valuable role in the disease management.

AB - OBJECTIVE: To review treatment results of high-risk metastatic gestational trophoblastic neoplasia (GTN) over the last 40 years in Hungary. STUDY DESIGN: Between January 1, 1977, and December 31, 2016, 197 patients were treated with high-risk metastatic GTN. Primary chemotherapy was selected based upon the patient’s stage of GTN and prognostic score. Surgery was performed mainly to either resect sites of chemotherapy-resistant disease or to treat acute complications. RESULTS: As a primary therapy, MAC was used in 124 high-risk cases and EMA-CO in 42 high-risk cases; out of those cases, 114 (91.9%) and 33 (78.6%) patients, respectively, achieved complete remission. As compared to the administration of the MAC regimen, during the last 10 years the use of EMA-CO primary combination chemotherapy had favorable outcomes and was significantly increased among our metastatic highrisk patients with more serious GTN (MAC/EMA-CO ratios between 1977–2006: 5.9 [100/17] and between 2007–2016: 0.9 [24/25]; p<0.05). Over the period of 1977–2016 54/197 (27.4%) hysterectomies were performed, while metastases were resected in 37/197 (18.8%) of high-risk patients. CONCLUSION: Patients with high-risk metastatic GTN should primarily be treated with EMA-CO com bination chemotherapy, while surgery still plays a valuable role in the disease management.

KW - Anatomical stages

KW - Chemotherapy

KW - Choriocarcinoma

KW - Gestational trophoblastic disease

KW - Gestational trophoblastic neoplasia

KW - High-risk metastatic gestational trophoblastic neoplasia

KW - Hysterectomy

KW - Metastasis surgery

KW - Prognostic score

UR - http://www.scopus.com/inward/record.url?scp=85048032711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048032711&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85048032711

VL - 63

SP - 240

EP - 248

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 3

ER -